ArticleJournal of neurology2024

Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study.

Ferdinando Clarelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.